Turk J Hematol. 2024; 41(3): 202-204 | DOI: 10.4274/tjh.galenos.2024.2024.0044
Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report
Kongfei Li, Yuxiao Wang, RenZhi Pei, Ying Lu, Junjie Cao, Xianxu Zhuang, Jiaying Lian, Bibo ZhangThe Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, China; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, China
Keywords: Mixed-phenotype acute leukemia, Targeted therapy, Inotuzumab ozogamicin
Mikst Fenotip Akut Lösemi Tedavisinde Kalikamisin-Inotuzumab Ozogamisin ile Kombine Venetoclax + Azasitidin Rejimi: Olgu Sunumu
Kongfei Li, Yuxiao Wang, RenZhi Pei, Ying Lu, Junjie Cao, Xianxu Zhuang, Jiaying Lian, Bibo ZhangThe Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, China; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, China
Anahtar Kelimeler: Mikst fenotip akut lösemi, Hedefe yönelik tedavi, İnotuzumab ozogamisin
Corresponding Author: Kongfei Li
Manuscript Language: English